97 related articles for article (PubMed ID: 34252573)
1. Incident detection of human papillomavirus - a prospective follow-up study among Tanzanian women with a focus on HIV status.
Mchome B; Linde DS; Manongi R; Waldstroem M; Lftner T; Wu C; Mwaisalage J; Rasch V; Kjaer SK
Int J Infect Dis; 2021 Sep; 110():165-170. PubMed ID: 34252573
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020.
Boni SP; Tenet V; Horo A; Heideman DAM; Bleeker MCG; Tanon A; Mian B; Mohenou ID; Ekouevi DK; Gheit T; Didi-Kouko Coulibaly J; Tchounga BK; Adoubi I; Clifford GM; Jaquet A;
Int J Cancer; 2024 Mar; 154(6):962-968. PubMed ID: 37942579
[TBL] [Abstract][Full Text] [Related]
3. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
[TBL] [Abstract][Full Text] [Related]
4. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
Kelly HA; Ngou J; Chikandiwa A; Sawadogo B; Gilham C; Omar T; Lompo O; Doutre S; Meda N; Weiss HA; Delany-Moretlwe S; Segondy M; Mayaud P;
PLoS One; 2017; 12(3):e0174117. PubMed ID: 28333966
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
6. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
Liu G; Mugo NR; Brown ER; Mgodi NM; Chirenje ZM; Marrazzo JM; Winer RL; Mansoor L; Palanee-Phillips T; Siva SS; Naidoo L; Jeenarain N; Gaffoor Z; Nair GL; Selepe P; Nakabiito C; Mkhize B; Mirembe BG; Taljaard M; Panchia R; Baeten JM; Balkus JE; Hladik F; Celum CL; Barnabas RV
AIDS; 2022 Feb; 36(2):257-265. PubMed ID: 34172672
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
Piyathilake CJ; Kumar R; Crowley MR; Badiga S; Burkholder GA
J Obstet Gynaecol Res; 2021 Jun; 47(6):2185-2195. PubMed ID: 33754434
[TBL] [Abstract][Full Text] [Related]
8. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
11. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
Mchome B; Swai P; Wu C; Katanga J; Kahesa C; Manongi R; Mwaiselage JD; Kjaer S; Rasch V; Linde DS
BMJ Open; 2020 Sep; 10(9):e038531. PubMed ID: 32948569
[TBL] [Abstract][Full Text] [Related]
14. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
15. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
16. The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.
Tong Y; Orang'o E; Nakalembe M; Tonui P; Itsura P; Muthoka K; Titus M; Kiptoo S; Mwangi A; Ong'echa J; Tonui R; Odongo B; Mpamani C; Rosen B; Moormann A; Cu-Uvin S; Bailey JA; Oduor CI; Ermel A; Yiannoutsos C; Musick B; Sang E; Ngeresa A; Banturaki G; Kiragga A; Zhang J; Song Y; Chintala S; Katzenellenbogen R; Loehrer P; Brown DR
Ann Med; 2022 Dec; 54(1):1202-1211. PubMed ID: 35521812
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
18. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
[TBL] [Abstract][Full Text] [Related]
19. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
20. Cervical HPV infection in Romanian women infected with HIV during early childhood.
Ene L; Voinea C; Stefanescu C; Sima D; Duiculescu D; Mehta SR
Int J STD AIDS; 2016 Oct; 27(12):1079-1085. PubMed ID: 26404111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
